Aim. Sarcoidosis is a heterogeneous disorder with a strong genetic influence. Genetic factors are also thought to influence disease severity and outcome. We sought to determine whether polymorphisms within CCR2 gene predispose to Lo¨fgren’s syndrome – a clinically and genetically distinct sarcoidosis phenotype – and, importantly, whether this association is independent of the known association with the HLADRB1* 0301 allele. Methods. We investigated 5 CCR2 variants and HLADRB1* 0301 by sequence-specific primer (SSP) polymerase chain reaction (PCR) in 176 Spanish (76 Lo¨fgren’s syndrome, 100 controls) and 387 Swedish subjects (126 Lo¨fgren’s syndrome, 77 non-Lo¨fgren sarcoidosis, 184 controls). Results. One of the deduced haplotypes (CCR2 haplotype 2) was associated with Lo¨fgren’s syndrome in both Spanish (OR: 2.03, uncorrected P = 0.02; permuted P = 0.041 vs. controls) and Swedish patients (OR: 3.02, uncorrected P = 0.0007; permuted P = 0.0027 vs. non-Lo¨fgren sarcoidosis; OR: 2.46, uncorrected P = 0.0005; permuted P = 0.0031 vs. controls). HLA-DRB1*0301 allele frequency was also increased in Spanish (OR: 3.52, P = 0.0004 vs. controls) and Swedish patients with Lo¨fgren’s syndrome (OR: 10.98, P < 0.0001 vs. non-Lo¨fgren sarcoidosis, OR: 7.71, P < 0.0001 vs. controls). Finally, multivariate analysis revealed that the CCR2 association was independent of HLA-DRB1*0301 in both Spanish (P = 0.02 vs. controls) and Swedish cohorts (P = 0.002 vs. non-Lo¨fgren sarcoidosis, P = 0.001 vs. controls). Conclusions. This study confirms that CCR2 haplotype 2 and HLA-DRB1*0301 are independent genetic risk factors for Lo¨fgren’s syndrome

A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren’s syndrome / Spagnolo, Paolo; Sato, H; Grunewald, J; Brynedal, B; Hillert, J; Mañá, J; Wells, Au; Eklund, A; Welsh, Ki; du Bois, Rm. - In: JOURNAL OF INTERNAL MEDICINE. - ISSN 0954-6820. - STAMPA. - 264:5(2008), pp. 433-441. [10.1111/j.1365-2796.2008.01984.x]

A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren’s syndrome

SPAGNOLO, Paolo;
2008

Abstract

Aim. Sarcoidosis is a heterogeneous disorder with a strong genetic influence. Genetic factors are also thought to influence disease severity and outcome. We sought to determine whether polymorphisms within CCR2 gene predispose to Lo¨fgren’s syndrome – a clinically and genetically distinct sarcoidosis phenotype – and, importantly, whether this association is independent of the known association with the HLADRB1* 0301 allele. Methods. We investigated 5 CCR2 variants and HLADRB1* 0301 by sequence-specific primer (SSP) polymerase chain reaction (PCR) in 176 Spanish (76 Lo¨fgren’s syndrome, 100 controls) and 387 Swedish subjects (126 Lo¨fgren’s syndrome, 77 non-Lo¨fgren sarcoidosis, 184 controls). Results. One of the deduced haplotypes (CCR2 haplotype 2) was associated with Lo¨fgren’s syndrome in both Spanish (OR: 2.03, uncorrected P = 0.02; permuted P = 0.041 vs. controls) and Swedish patients (OR: 3.02, uncorrected P = 0.0007; permuted P = 0.0027 vs. non-Lo¨fgren sarcoidosis; OR: 2.46, uncorrected P = 0.0005; permuted P = 0.0031 vs. controls). HLA-DRB1*0301 allele frequency was also increased in Spanish (OR: 3.52, P = 0.0004 vs. controls) and Swedish patients with Lo¨fgren’s syndrome (OR: 10.98, P < 0.0001 vs. non-Lo¨fgren sarcoidosis, OR: 7.71, P < 0.0001 vs. controls). Finally, multivariate analysis revealed that the CCR2 association was independent of HLA-DRB1*0301 in both Spanish (P = 0.02 vs. controls) and Swedish cohorts (P = 0.002 vs. non-Lo¨fgren sarcoidosis, P = 0.001 vs. controls). Conclusions. This study confirms that CCR2 haplotype 2 and HLA-DRB1*0301 are independent genetic risk factors for Lo¨fgren’s syndrome
2008
264
5
433
441
A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren’s syndrome / Spagnolo, Paolo; Sato, H; Grunewald, J; Brynedal, B; Hillert, J; Mañá, J; Wells, Au; Eklund, A; Welsh, Ki; du Bois, Rm. - In: JOURNAL OF INTERNAL MEDICINE. - ISSN 0954-6820. - STAMPA. - 264:5(2008), pp. 433-441. [10.1111/j.1365-2796.2008.01984.x]
Spagnolo, Paolo; Sato, H; Grunewald, J; Brynedal, B; Hillert, J; Mañá, J; Wells, Au; Eklund, A; Welsh, Ki; du Bois, Rm
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/983386
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 37
social impact